切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2019, Vol. 13 ›› Issue (06) : 467 -471. doi: 10.3877/cma.j.issn.1674-1358.2019.06.002

所属专题: 文献

综述

乳酸杆菌与肝病研究进展
全敏1, 邢卉春1,()   
  1. 1. 100015 北京,首都医科大学附属北京地坛医院肝病三科
  • 收稿日期:2019-01-11 出版日期:2019-12-15
  • 通信作者: 邢卉春
  • 基金资助:
    北京市重点实验室开放研究课题(No. DTKF201704); 北京市医院管理局消化内科学科协同发展中心项目(No. XXT26); 北京市医院管理局扬帆计划(No. XMLX201837); "十三五"艾滋病和病毒性肝炎等重大传染病防治(No. 2018ZX10302206-003-006); 吴阶平医学基金会(No. LDWJPMF-103-17001)

Progress on Lactobacillus and liver diseases

Min Quan1, Huichun Xing1,()   

  1. 1. Department of Hepatology Division 3rd, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
  • Received:2019-01-11 Published:2019-12-15
  • Corresponding author: Huichun Xing
  • About author:
    Corresponding author: Xing Huichun, Email:
引用本文:

全敏, 邢卉春. 乳酸杆菌与肝病研究进展[J]. 中华实验和临床感染病杂志(电子版), 2019, 13(06): 467-471.

Min Quan, Huichun Xing. Progress on Lactobacillus and liver diseases[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2019, 13(06): 467-471.

近年来肠道微生态与多种肝病的发生、发展受到越来越多的关注。益生菌因具有改善肠道屏障、激活免疫功能等多种有利于人体的功能而日益受到重视。乳酸杆菌作为主要的益生菌之一,与多种肝脏疾病的发生、发展和预后相关,尤其在酒精性脂肪肝及非酒精性脂肪肝治疗中作用的研究日益增多。不同乳酸杆菌与不同肝病的关系亦不尽相同,为临床应用乳酸杆菌调节肠道菌群及治疗肝病提供参考,本文就乳酸杆菌与肝病相关性及在肝病治疗中的应用作一综述。

In recent years, more and more attention has been paid to the relationship between intestinal microecology and the occurrence and development of various liver diseases. Probiotics are getting more and more attention due to their beneficial functions such as improving intestinal barrier and activating immune function. Lactobacillus, as one of the main probiotics, is associated with the occurrence, development and prognosis of various liver diseases, especially in the treatment of alcoholic fatty liver disease and non-alcoholic fatty liver disease. In order to provide reference for the clinical application of Lactobacillus in the regulation of intestinal flora in the treatment of liver diseases, this paper reviews the correlation between Lactobacillus and liver diseases and its application in the treatment of liver diseases.

[1]
Lachar J, Bajaj JS. Changes in the Microbiome in cirrhosis and relationship to complications: Hepatic encephalopathy, spontaneous bacterial peritonitis, and sepsis[J]. Semin Liver Dis,2016,36(4):327-330.
[2]
Marteau P, Shanahan F. Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects[J]. Best Pract Res Clin Gastroenterol,2003,17(5):725-740.
[3]
Ou CC, Lin SL, Tsai JJ, et al. Heat-killed lactic acid bacteria enhance immunomodulatory potential by skewing the immune response toward Th1 polarization[J]. J Food Sci,2011,76(5):M260-267.
[4]
Conway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells[J]. J Dairy Sci,1987,70(1):1-12.
[5]
Zhang M, Wang C, Wang C, et al. Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease[J]. J Nutr Biochem,2015,26(4):337-344.
[6]
Chen RC, Xu LM, Du SJ, et al. Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances Treg and TH17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding[J]. Toxicol Lett,2016,241:103-110.
[7]
Wang Y, Liu Y, Kirpich I, et al. Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury[J]. J Nutr Biochem,2013,24(9):1609-1615.
[8]
Wang Y, Liu Y, Sidhu A, et al. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury[J]. Am J Physiol Gastrointest Liver Physiol,2012,303(1):G32-41.
[9]
Kim B, Park KY, Ji Y, et al. Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice[J]. Biochem Biophys Res Commun,2016,473(2):530-536.
[10]
Hammes TO, Leke R, TDC E, et al. Lactobacillus rhamnosus GG reduces hepatic fibrosis in a model of chronic liver disease in rats[J]. Nutr Hosp,2017,34(3):702-709.
[11]
Bajaj JS, Heuman DM, Hylemon PB, et al. Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis[J]. Aliment Pharmacol Ther,2014,39(10):1113-1125.
[12]
Messaoudi S, Manai M, Kergourlay G, et al. Lactobacillus salivarius: bacteriocin and probiotic activity[J]. Food Microbiol,2013,36(2):296- 304.
[13]
Guo J, Brosnan B, Furey A, et al. Antifungal activity of Lactobacillus against microsporum canis, microsporum gypseum and epidermophyton floccosum[J]. Bioeng Bugs,2012,3(2):104-113.
[14]
Steinberg RS, Silva LC, Souza TC, et al. Safety and protective effectiveness of two strains of Lactobacillus with probiotic features in an experimental model of salmonellosis[J]. Int J Environ Res Public Health,2014,11(9):8755-8776.
[15]
Drago L, De Vecchi E, Gabrieli A, et al. Immunomodulatory effects of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03, alone and in combination, on peripheral blood mononuclear cells of allergic asthmatics[J]. Allergy Asthma Immunol Res,2015,7(4):409-413.
[16]
Lv LX, Hu XJ, Qian GR, et al. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 improves acute liver injury induced by D-galactosamine in rats[J]. Appl Microbiol Biotechnol,2014,98(12):5619-5632.
[17]
Lv LX, Yan R, Shi HY, et al. Integrated transcriptomic and proteomic analysis of the bile stress response in probiotic Lactobacillus salivarius LI01[J]. J Proteomics,2017,150:216-229.
[18]
Shi D, Lv L, Fang D, et al. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats[J]. Sci Rep,2017,7(1):6927-6940.
[19]
Chuang CH, Tsai CC, Lin ES, et al. Heat-killed Lactobacillus salivarius and Lactobacillus johnsonii reduce liver injury induced by alcohol in vitro and in vivo[J]. Molecules,2016,21(11):1456-1467.
[20]
Nan B, Liu YL, You Y, et al. Protective effects of enhanced minor ginsenosides in Lactobacillus fermentum KP-3-fermented ginseng in mice fed a high fat diet[J]. Food Funct,2018,9(11):6020-6028.
[21]
Yadav R, Khan SH, Mada SB, et al. Consumption of probiotic Lactobacillus fermentum MTCC: 5898-fermented milk attenuates dyslipidemia, oxidative stress, and inflammation in male rats fed on cholesterol-enriched diet[J]. Probiotics Antimicrob Proteins,2018,
[22]
Rivero-Gutiérrez B, Gámez-Belmonte R, Suárez MD, et al. A synbiotic composed of Lactobacillus fermentum CECT5716 and FOS prevents the development of fatty acid liver and glycemic alterations in rats fed a high fructose diet associated with changes in the microbiota[J]. Mol Nutr Food Res,2017,61(8):201600622.
[23]
Jin P, Chen Y, Lv L, et al. Lactobacillus fermentum ZYL0401 attenuates lipopolysaccharide-induced hepatic TNF-α expression and liver injury via an IL-10- and PGE2-EP4-dependent mechanism[J]. PLoS One,2015,10(5):e0126520.
[24]
Kim BK, Lee IO, Tan PL, et al. Protective effect of Lactobacillus fermentum LA12 in an alcohol-induced rat model of alcoholic steatohepatitis[J]. Korean J Food Sci Anim Resour,2017,37(6):931-939.
[25]
Stadlbauer V, Mookerjee RP, Hodges S, et al. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis[J]. J Hepatol,2008,48(6):945-951.
[26]
Ren T, Huang C, Cheng M. Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway[J]. Oxid Med Cell Longev,2014,2014:469059.
[27]
Wagnerberger S, Spruss A, Kanuri G, et al. Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model[J]. J Nutr Biochem,2013,24(3):531-538.
[28]
Zhao D, Wu T, Yi D, et al. Dietary supplementation with Lactobacillus casei alleviates Lipopolysaccharide-induced liver injury in a porcine model[J]. Int J Mol Sci,2017,18(12):2535-2547.
[29]
Zhang H, Wang Y, Sun J, et al. Safety evaluation of Lactobacillus paracasei subsp. paracasei LC-01, a probiotic bacterium[J]. J Microbiol,2013,51(5):633-638.
[30]
Ye H, Li Q, Zhang Z, et al. Effect of a novel potential probiotic Lactobacillus paracasei Jlus66 isolated from fermented milk on nonalcoholic fatty liver in rats[J]. Food Funct,2017,8(12):4539-4546.
[31]
Park SS, Lee YJ, Song S, et al. Lactobacillus acidophilus NS1 attenuates diet-induced obesity and fatty liver[J]. J Endocrinol,2018,237(2):87-100.
[32]
Li C, Nie SP, Zhu KX, et al. Lactobacillus plantarum NCU116 improves liver function, oxidative stress and lipid metabolism in rats with high fat diet induced non-alcoholic fatty liver disease[J]. Food Funct,2014,5(12):3216-3223.
[33]
Miyoshi M, Ogawa A, Higurashi S, et al. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice[J]. Eur J Nutr,2014,53(2):599-606.
[1] 刘婷婷, 林妍冰, 汪珊, 陈幕荣, 唐子鉴, 代东伶, 夏焙. 超声衰减参数成像评价儿童代谢相关脂肪性肝病的价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 787-794.
[2] . 肝移植治疗终末期肝病[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 1-.
[3] 李丹阳, 李满祥. 肠道菌群失调在肺动脉高压发病中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 432-434.
[4] 何吉鑫, 杨燕妮, 王继伟, 李建国, 谢铭. 肠道菌群及肠道代谢产物参与慢性便秘发生机制的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 495-499.
[5] 乔小梅, 孔凯丽, 方敬爱, 张晓东. "肠-皮肤轴"与尿毒症皮肤病变的关系研究进展[J]. 中华肾病研究电子杂志, 2023, 12(05): 291-294.
[6] 李娜, 朱国贞. 肠道菌群及其代谢产物在急性肾损伤中的作用研究进展[J]. 中华肾病研究电子杂志, 2023, 12(04): 215-219.
[7] 王宁, 刘彦哲, 吴紫莺, 曾超, 雷光华, 沙婷婷, 王伊伦. 基于孟德尔随机化研究探讨肠道菌群与肌少症表型的因果关联[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 333-342.
[8] 孙晗, 武侠. 成人肠易激综合征患者肠道菌群特征与不同分型患者生活质量和精神症状的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 461-465.
[9] 屈霄, 王靓, 陆萍, 何斌, 孙敏. 外周血炎症因子及肠道菌群特征与活动性溃疡性结肠炎患者病情的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 466-470.
[10] 廖想, 李爽, 曾瑶. 2012-2021年粪菌移植研究的趋势及热点分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(02): 93-99.
[11] 张大涯, 陈世锔, 陈润祥, 张晓冬, 李达, 白飞虎. 肠道微生物群对代谢相关脂肪性肝病发展的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 828-833.
[12] 韩家超, 王飞飞, 柳子宁, 胡冀陶, 孟泽松, 雒月云, 王贵英. 二甲双胍的作用机制研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(03): 349-355.
[13] 杜青瑶, 曹颖雯, 林健雄, 郝润, 王静敏, 徐锐权, 寇晓霞. 肠道菌群促进诺如病毒感染的机制[J]. 中华临床实验室管理电子杂志, 2023, 11(04): 241-244,255.
[14] 刘艳, 唐神结. 肠道菌群与抗结核药及其所致肝损伤的相关性研究进展[J]. 中华诊断学电子杂志, 2023, 11(02): 82-86.
[15] 金泽平, 董晶, 柳云鹏, 汪阳. 菌群-肠道-脑轴与缺血性卒中危险因素关系的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 510-517.
阅读次数
全文


摘要